ALS Learning Series
The ALS Exposome: How Environmental Exposures Inform Disease Risk and Prevention
April 25, 2025
Inspired by his patients, Dr. Goutman’s research focuses on identifying new mechanisms and therapies for ALS. Specifically, he has been seeking to understand the genetic and environmental interactions that alter susceptibility to ALS, especially in the State of Michigan, which has some of the highest rates of ALS in the country. With funding from the National Institutes of Health, the Centers for Disease Control and Prevention, and the ALS Association, he is discovering environmental risk factors associated with the onset and progression of ALS by collecting epidemiologic exposure surveys and biofluids from individuals with and without ALS. He shares an ultimate goal to one day make ALS a preventable disease.
Dr. Goutman's MiBrain study is linked here
The EXPOSE study, for those with a family history of ALS, is linked here
Note that because of technical difficulties, Dr. Goutman's session was not recorded. This is his presentation for one of our partners, NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium).
ALS Learning Series Sponsors
